Retina Implant to join with Wills Eye for U.S. artificial vision clinical trial
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced that they will partner with the Wills Eye Institute in Philadelphia as the lead U.S. clinical trial investigator site.